nodes	percent_of_prediction	percent_of_DWPC	metapath
Galantamine—CHRND—pericardium—sarcoma	0.0481	0.132	CbGeAlD
Galantamine—CHRNA9—embryo—sarcoma	0.0227	0.0621	CbGeAlD
Galantamine—BCHE—diaphragm—sarcoma	0.0221	0.0603	CbGeAlD
Galantamine—CHRNG—myometrium—sarcoma	0.0123	0.0336	CbGeAlD
Galantamine—CHRNE—testis—sarcoma	0.0116	0.0317	CbGeAlD
Galantamine—CHRNG—seminal vesicle—sarcoma	0.0111	0.0304	CbGeAlD
Galantamine—CHRNA6—skin of body—sarcoma	0.00975	0.0266	CbGeAlD
Galantamine—CHRNA2—mammary gland—sarcoma	0.00953	0.026	CbGeAlD
Galantamine—CHRNA10—hematopoietic system—sarcoma	0.00896	0.0245	CbGeAlD
Galantamine—CHRNA5—testis—sarcoma	0.00811	0.0222	CbGeAlD
Galantamine—CHRNB2—myometrium—sarcoma	0.0075	0.0205	CbGeAlD
Galantamine—CHRNA1—hematopoietic system—sarcoma	0.007	0.0191	CbGeAlD
Galantamine—CHRNG—tendon—sarcoma	0.00699	0.0191	CbGeAlD
Galantamine—CHRNG—bone marrow—sarcoma	0.00678	0.0185	CbGeAlD
Galantamine—CHRNB4—tendon—sarcoma	0.00674	0.0184	CbGeAlD
Galantamine—CHRNA10—lymphoid tissue—sarcoma	0.00631	0.0172	CbGeAlD
Galantamine—CHRNA3—hematopoietic system—sarcoma	0.00625	0.0171	CbGeAlD
Galantamine—CHRNA10—tendon—sarcoma	0.00593	0.0162	CbGeAlD
Galantamine—CHRNA5—lymph node—sarcoma	0.00588	0.0161	CbGeAlD
Galantamine—CHRNB2—smooth muscle tissue—sarcoma	0.00567	0.0155	CbGeAlD
Galantamine—CHRNB4—testis—sarcoma	0.00558	0.0152	CbGeAlD
Galantamine—CHRND—tendon—sarcoma	0.00555	0.0152	CbGeAlD
Galantamine—CHRNA3—skin of body—sarcoma	0.00543	0.0148	CbGeAlD
Galantamine—CHRFAM7A—hematopoietic system—sarcoma	0.00505	0.0138	CbGeAlD
Galantamine—CHRNA1—lymphoid tissue—sarcoma	0.00493	0.0135	CbGeAlD
Galantamine—CHRNA10—testis—sarcoma	0.00491	0.0134	CbGeAlD
Galantamine—CHRNB2—uterus—sarcoma	0.00486	0.0133	CbGeAlD
Galantamine—CHRNA1—tendon—sarcoma	0.00463	0.0127	CbGeAlD
Galantamine—CHRNA3—lymphoid tissue—sarcoma	0.0044	0.012	CbGeAlD
Galantamine—CHRNB2—tendon—sarcoma	0.00426	0.0116	CbGeAlD
Galantamine—CHRNB2—bone marrow—sarcoma	0.00413	0.0113	CbGeAlD
Galantamine—CHRNA7—hematopoietic system—sarcoma	0.00408	0.0111	CbGeAlD
Galantamine—CHRNA4—hematopoietic system—sarcoma	0.00402	0.011	CbGeAlD
Galantamine—CHRNB1—tendon—sarcoma	0.00358	0.00977	CbGeAlD
Galantamine—CHRNA10—lymph node—sarcoma	0.00356	0.00973	CbGeAlD
Galantamine—CHRNA7—skin of body—sarcoma	0.00355	0.00969	CbGeAlD
Galantamine—CHRNB2—testis—sarcoma	0.00353	0.00964	CbGeAlD
Galantamine—CHRNA3—testis—sarcoma	0.00342	0.00935	CbGeAlD
Galantamine—CHRNB2—liver—sarcoma	0.00334	0.00912	CbGeAlD
Galantamine—ACHE—tendon—sarcoma	0.0031	0.00847	CbGeAlD
Galantamine—CHRNA7—uterus—sarcoma	0.00308	0.00842	CbGeAlD
Galantamine—CHRNB1—testis—sarcoma	0.00296	0.00809	CbGeAlD
Galantamine—CHRNB1—liver—sarcoma	0.0028	0.00765	CbGeAlD
Galantamine—CHRFAM7A—testis—sarcoma	0.00277	0.00756	CbGeAlD
Galantamine—BCHE—myometrium—sarcoma	0.00268	0.00733	CbGeAlD
Galantamine—ACHE—testis—sarcoma	0.00257	0.00701	CbGeAlD
Galantamine—CHRNB2—lymph node—sarcoma	0.00256	0.00699	CbGeAlD
Galantamine—CHRNA3—lymph node—sarcoma	0.00248	0.00678	CbGeAlD
Galantamine—BCHE—seminal vesicle—sarcoma	0.00242	0.00662	CbGeAlD
Galantamine—BCHE—hematopoietic system—sarcoma	0.0023	0.00629	CbGeAlD
Galantamine—CHRNA7—testis—sarcoma	0.00224	0.00611	CbGeAlD
Galantamine—CHRNB1—lymph node—sarcoma	0.00215	0.00586	CbGeAlD
Galantamine—BCHE—smooth muscle tissue—sarcoma	0.00203	0.00554	CbGeAlD
Galantamine—BCHE—skin of body—sarcoma	0.002	0.00547	CbGeAlD
Galantamine—ACHE—lymph node—sarcoma	0.00186	0.00508	CbGeAlD
Galantamine—BCHE—cardiac atrium—sarcoma	0.00175	0.00478	CbGeAlD
Galantamine—BCHE—uterus—sarcoma	0.00174	0.00475	CbGeAlD
Galantamine—CYP3A4—hematopoietic system—sarcoma	0.00155	0.00424	CbGeAlD
Galantamine—CYP2D6—hematopoietic system—sarcoma	0.00153	0.00417	CbGeAlD
Galantamine—BCHE—bone marrow—sarcoma	0.00148	0.00403	CbGeAlD
Galantamine—BCHE—testis—sarcoma	0.00126	0.00345	CbGeAlD
Galantamine—BCHE—liver—sarcoma	0.00119	0.00326	CbGeAlD
Galantamine—Hypersensitivity—Thiotepa—sarcoma	0.00104	0.00165	CcSEcCtD
Galantamine—Hypersensitivity—Dactinomycin—sarcoma	0.00104	0.00163	CcSEcCtD
Galantamine—Gastrointestinal pain—Vincristine—sarcoma	0.00103	0.00162	CcSEcCtD
Galantamine—Gastritis—Epirubicin—sarcoma	0.00103	0.00162	CcSEcCtD
Galantamine—Confusional state—Etoposide—sarcoma	0.00103	0.00162	CcSEcCtD
Galantamine—Muscular weakness—Epirubicin—sarcoma	0.00102	0.00161	CcSEcCtD
Galantamine—Asthenia—Thiotepa—sarcoma	0.00102	0.0016	CcSEcCtD
Galantamine—Ataxia—Doxorubicin—sarcoma	0.00101	0.00159	CcSEcCtD
Galantamine—Asthenia—Dactinomycin—sarcoma	0.00101	0.00159	CcSEcCtD
Galantamine—Feeling abnormal—Mitoxantrone—sarcoma	0.00101	0.00159	CcSEcCtD
Galantamine—Dysphagia—Epirubicin—sarcoma	0.001	0.00158	CcSEcCtD
Galantamine—Gastrointestinal pain—Mitoxantrone—sarcoma	0.001	0.00158	CcSEcCtD
Galantamine—Dehydration—Doxorubicin—sarcoma	0.000998	0.00157	CcSEcCtD
Galantamine—Thrombocytopenia—Etoposide—sarcoma	0.000996	0.00157	CcSEcCtD
Galantamine—Tachycardia—Etoposide—sarcoma	0.000993	0.00157	CcSEcCtD
Galantamine—Abdominal pain—Vincristine—sarcoma	0.000993	0.00157	CcSEcCtD
Galantamine—Body temperature increased—Vincristine—sarcoma	0.000993	0.00157	CcSEcCtD
Galantamine—Skin disorder—Etoposide—sarcoma	0.000988	0.00156	CcSEcCtD
Galantamine—Hyperhidrosis—Etoposide—sarcoma	0.000983	0.00155	CcSEcCtD
Galantamine—Abdominal pain upper—Doxorubicin—sarcoma	0.00098	0.00155	CcSEcCtD
Galantamine—Orthostatic hypotension—Doxorubicin—sarcoma	0.00098	0.00155	CcSEcCtD
Galantamine—Hypokalaemia—Doxorubicin—sarcoma	0.000977	0.00154	CcSEcCtD
Galantamine—Anorexia—Etoposide—sarcoma	0.00097	0.00153	CcSEcCtD
Galantamine—Diarrhoea—Thiotepa—sarcoma	0.000969	0.00153	CcSEcCtD
Galantamine—Abdominal pain—Mitoxantrone—sarcoma	0.000967	0.00152	CcSEcCtD
Galantamine—Body temperature increased—Mitoxantrone—sarcoma	0.000967	0.00152	CcSEcCtD
Galantamine—Bronchitis—Epirubicin—sarcoma	0.000964	0.00152	CcSEcCtD
Galantamine—Diarrhoea—Dactinomycin—sarcoma	0.000962	0.00152	CcSEcCtD
Galantamine—Hypotension—Etoposide—sarcoma	0.000951	0.0015	CcSEcCtD
Galantamine—Gastritis—Doxorubicin—sarcoma	0.00095	0.0015	CcSEcCtD
Galantamine—Muscular weakness—Doxorubicin—sarcoma	0.000947	0.00149	CcSEcCtD
Galantamine—Dizziness—Thiotepa—sarcoma	0.000936	0.00148	CcSEcCtD
Galantamine—Upper respiratory tract infection—Epirubicin—sarcoma	0.000932	0.00147	CcSEcCtD
Galantamine—Dysphagia—Doxorubicin—sarcoma	0.000928	0.00146	CcSEcCtD
Galantamine—Pollakiuria—Epirubicin—sarcoma	0.000926	0.00146	CcSEcCtD
Galantamine—Hypersensitivity—Vincristine—sarcoma	0.000925	0.00146	CcSEcCtD
Galantamine—BCHE—lymph node—sarcoma	0.000914	0.0025	CbGeAlD
Galantamine—Paraesthesia—Etoposide—sarcoma	0.000913	0.00144	CcSEcCtD
Galantamine—Weight decreased—Epirubicin—sarcoma	0.000907	0.00143	CcSEcCtD
Galantamine—Hyperglycaemia—Epirubicin—sarcoma	0.000905	0.00143	CcSEcCtD
Galantamine—Somnolence—Etoposide—sarcoma	0.000904	0.00143	CcSEcCtD
Galantamine—Hypersensitivity—Mitoxantrone—sarcoma	0.000901	0.00142	CcSEcCtD
Galantamine—Asthenia—Vincristine—sarcoma	0.000901	0.00142	CcSEcCtD
Galantamine—Vomiting—Thiotepa—sarcoma	0.0009	0.00142	CcSEcCtD
Galantamine—Pneumonia—Epirubicin—sarcoma	0.000899	0.00142	CcSEcCtD
Galantamine—Vomiting—Dactinomycin—sarcoma	0.000894	0.00141	CcSEcCtD
Galantamine—Rash—Thiotepa—sarcoma	0.000893	0.00141	CcSEcCtD
Galantamine—Bronchitis—Doxorubicin—sarcoma	0.000892	0.00141	CcSEcCtD
Galantamine—Dermatitis—Thiotepa—sarcoma	0.000892	0.00141	CcSEcCtD
Galantamine—Headache—Thiotepa—sarcoma	0.000887	0.0014	CcSEcCtD
Galantamine—Rash—Dactinomycin—sarcoma	0.000886	0.0014	CcSEcCtD
Galantamine—Decreased appetite—Etoposide—sarcoma	0.000884	0.00139	CcSEcCtD
Galantamine—Renal failure—Epirubicin—sarcoma	0.000879	0.00139	CcSEcCtD
Galantamine—Gastrointestinal disorder—Etoposide—sarcoma	0.000878	0.00139	CcSEcCtD
Galantamine—Asthenia—Mitoxantrone—sarcoma	0.000877	0.00138	CcSEcCtD
Galantamine—Fatigue—Etoposide—sarcoma	0.000877	0.00138	CcSEcCtD
Galantamine—Neuropathy peripheral—Epirubicin—sarcoma	0.000876	0.00138	CcSEcCtD
Galantamine—Constipation—Etoposide—sarcoma	0.00087	0.00137	CcSEcCtD
Galantamine—Urinary tract infection—Epirubicin—sarcoma	0.000869	0.00137	CcSEcCtD
Galantamine—Upper respiratory tract infection—Doxorubicin—sarcoma	0.000862	0.00136	CcSEcCtD
Galantamine—Diarrhoea—Vincristine—sarcoma	0.000859	0.00136	CcSEcCtD
Galantamine—Pollakiuria—Doxorubicin—sarcoma	0.000857	0.00135	CcSEcCtD
Galantamine—Haematuria—Epirubicin—sarcoma	0.000852	0.00134	CcSEcCtD
Galantamine—Hepatobiliary disease—Epirubicin—sarcoma	0.000846	0.00133	CcSEcCtD
Galantamine—Epistaxis—Epirubicin—sarcoma	0.000843	0.00133	CcSEcCtD
Galantamine—Nausea—Thiotepa—sarcoma	0.000841	0.00133	CcSEcCtD
Galantamine—Weight decreased—Doxorubicin—sarcoma	0.000839	0.00132	CcSEcCtD
Galantamine—Feeling abnormal—Etoposide—sarcoma	0.000838	0.00132	CcSEcCtD
Galantamine—Hyperglycaemia—Doxorubicin—sarcoma	0.000837	0.00132	CcSEcCtD
Galantamine—Diarrhoea—Mitoxantrone—sarcoma	0.000837	0.00132	CcSEcCtD
Galantamine—CYP2D6—testis—sarcoma	0.000836	0.00228	CbGeAlD
Galantamine—Nausea—Dactinomycin—sarcoma	0.000835	0.00132	CcSEcCtD
Galantamine—Pneumonia—Doxorubicin—sarcoma	0.000832	0.00131	CcSEcCtD
Galantamine—Gastrointestinal pain—Etoposide—sarcoma	0.000832	0.00131	CcSEcCtD
Galantamine—Dizziness—Vincristine—sarcoma	0.00083	0.00131	CcSEcCtD
Galantamine—Bradycardia—Epirubicin—sarcoma	0.000817	0.00129	CcSEcCtD
Galantamine—Renal failure—Doxorubicin—sarcoma	0.000813	0.00128	CcSEcCtD
Galantamine—Neuropathy peripheral—Doxorubicin—sarcoma	0.000811	0.00128	CcSEcCtD
Galantamine—Haemoglobin—Epirubicin—sarcoma	0.000807	0.00127	CcSEcCtD
Galantamine—Rhinitis—Epirubicin—sarcoma	0.000805	0.00127	CcSEcCtD
Galantamine—Abdominal pain—Etoposide—sarcoma	0.000804	0.00127	CcSEcCtD
Galantamine—Body temperature increased—Etoposide—sarcoma	0.000804	0.00127	CcSEcCtD
Galantamine—Urinary tract infection—Doxorubicin—sarcoma	0.000804	0.00127	CcSEcCtD
Galantamine—CYP3A4—liver—sarcoma	0.000803	0.00219	CbGeAlD
Galantamine—Haemorrhage—Epirubicin—sarcoma	0.000803	0.00127	CcSEcCtD
Galantamine—Hepatitis—Epirubicin—sarcoma	0.000803	0.00127	CcSEcCtD
Galantamine—Vomiting—Vincristine—sarcoma	0.000798	0.00126	CcSEcCtD
Galantamine—Urinary tract disorder—Epirubicin—sarcoma	0.000793	0.00125	CcSEcCtD
Galantamine—Rash—Vincristine—sarcoma	0.000792	0.00125	CcSEcCtD
Galantamine—Dermatitis—Vincristine—sarcoma	0.000791	0.00125	CcSEcCtD
Galantamine—Oedema peripheral—Epirubicin—sarcoma	0.000791	0.00125	CcSEcCtD
Galantamine—CYP2D6—liver—sarcoma	0.00079	0.00216	CbGeAlD
Galantamine—Haematuria—Doxorubicin—sarcoma	0.000789	0.00124	CcSEcCtD
Galantamine—Connective tissue disorder—Epirubicin—sarcoma	0.000789	0.00124	CcSEcCtD
Galantamine—Urethral disorder—Epirubicin—sarcoma	0.000787	0.00124	CcSEcCtD
Galantamine—Headache—Vincristine—sarcoma	0.000787	0.00124	CcSEcCtD
Galantamine—Hepatobiliary disease—Doxorubicin—sarcoma	0.000782	0.00123	CcSEcCtD
Galantamine—Epistaxis—Doxorubicin—sarcoma	0.00078	0.00123	CcSEcCtD
Galantamine—Vomiting—Mitoxantrone—sarcoma	0.000778	0.00123	CcSEcCtD
Galantamine—Visual impairment—Epirubicin—sarcoma	0.000773	0.00122	CcSEcCtD
Galantamine—Rash—Mitoxantrone—sarcoma	0.000771	0.00122	CcSEcCtD
Galantamine—Dermatitis—Mitoxantrone—sarcoma	0.00077	0.00122	CcSEcCtD
Galantamine—Headache—Mitoxantrone—sarcoma	0.000766	0.00121	CcSEcCtD
Galantamine—Bradycardia—Doxorubicin—sarcoma	0.000756	0.00119	CcSEcCtD
Galantamine—Eye disorder—Epirubicin—sarcoma	0.00075	0.00118	CcSEcCtD
Galantamine—Hypersensitivity—Etoposide—sarcoma	0.000749	0.00118	CcSEcCtD
Galantamine—Tinnitus—Epirubicin—sarcoma	0.000748	0.00118	CcSEcCtD
Galantamine—Haemoglobin—Doxorubicin—sarcoma	0.000746	0.00118	CcSEcCtD
Galantamine—Nausea—Vincristine—sarcoma	0.000746	0.00118	CcSEcCtD
Galantamine—Cardiac disorder—Epirubicin—sarcoma	0.000745	0.00117	CcSEcCtD
Galantamine—Flushing—Epirubicin—sarcoma	0.000745	0.00117	CcSEcCtD
Galantamine—Rhinitis—Doxorubicin—sarcoma	0.000745	0.00117	CcSEcCtD
Galantamine—Haemorrhage—Doxorubicin—sarcoma	0.000743	0.00117	CcSEcCtD
Galantamine—Hepatitis—Doxorubicin—sarcoma	0.000743	0.00117	CcSEcCtD
Galantamine—Urinary tract disorder—Doxorubicin—sarcoma	0.000733	0.00116	CcSEcCtD
Galantamine—Oedema peripheral—Doxorubicin—sarcoma	0.000732	0.00115	CcSEcCtD
Galantamine—Asthenia—Etoposide—sarcoma	0.00073	0.00115	CcSEcCtD
Galantamine—Connective tissue disorder—Doxorubicin—sarcoma	0.00073	0.00115	CcSEcCtD
Galantamine—Angiopathy—Epirubicin—sarcoma	0.000728	0.00115	CcSEcCtD
Galantamine—Urethral disorder—Doxorubicin—sarcoma	0.000728	0.00115	CcSEcCtD
Galantamine—Nausea—Mitoxantrone—sarcoma	0.000726	0.00115	CcSEcCtD
Galantamine—Immune system disorder—Epirubicin—sarcoma	0.000725	0.00114	CcSEcCtD
Galantamine—Arrhythmia—Epirubicin—sarcoma	0.000717	0.00113	CcSEcCtD
Galantamine—Visual impairment—Doxorubicin—sarcoma	0.000716	0.00113	CcSEcCtD
Galantamine—Mental disorder—Epirubicin—sarcoma	0.000703	0.00111	CcSEcCtD
Galantamine—Malnutrition—Epirubicin—sarcoma	0.000699	0.0011	CcSEcCtD
Galantamine—Diarrhoea—Etoposide—sarcoma	0.000696	0.0011	CcSEcCtD
Galantamine—Eye disorder—Doxorubicin—sarcoma	0.000694	0.00109	CcSEcCtD
Galantamine—Tinnitus—Doxorubicin—sarcoma	0.000692	0.00109	CcSEcCtD
Galantamine—Cardiac disorder—Doxorubicin—sarcoma	0.000689	0.00109	CcSEcCtD
Galantamine—Flushing—Doxorubicin—sarcoma	0.000689	0.00109	CcSEcCtD
Galantamine—Flatulence—Epirubicin—sarcoma	0.000688	0.00109	CcSEcCtD
Galantamine—Tension—Epirubicin—sarcoma	0.000686	0.00108	CcSEcCtD
Galantamine—Dysgeusia—Epirubicin—sarcoma	0.000684	0.00108	CcSEcCtD
Galantamine—Nervousness—Epirubicin—sarcoma	0.000679	0.00107	CcSEcCtD
Galantamine—Back pain—Epirubicin—sarcoma	0.000676	0.00107	CcSEcCtD
Galantamine—Angiopathy—Doxorubicin—sarcoma	0.000674	0.00106	CcSEcCtD
Galantamine—Dizziness—Etoposide—sarcoma	0.000673	0.00106	CcSEcCtD
Galantamine—Muscle spasms—Epirubicin—sarcoma	0.000672	0.00106	CcSEcCtD
Galantamine—Immune system disorder—Doxorubicin—sarcoma	0.000671	0.00106	CcSEcCtD
Galantamine—Arrhythmia—Doxorubicin—sarcoma	0.000663	0.00105	CcSEcCtD
Galantamine—Vision blurred—Epirubicin—sarcoma	0.000658	0.00104	CcSEcCtD
Galantamine—Mental disorder—Doxorubicin—sarcoma	0.000651	0.00103	CcSEcCtD
Galantamine—Ill-defined disorder—Epirubicin—sarcoma	0.000648	0.00102	CcSEcCtD
Galantamine—Vomiting—Etoposide—sarcoma	0.000647	0.00102	CcSEcCtD
Galantamine—Malnutrition—Doxorubicin—sarcoma	0.000646	0.00102	CcSEcCtD
Galantamine—Anaemia—Epirubicin—sarcoma	0.000646	0.00102	CcSEcCtD
Galantamine—Agitation—Epirubicin—sarcoma	0.000642	0.00101	CcSEcCtD
Galantamine—Rash—Etoposide—sarcoma	0.000641	0.00101	CcSEcCtD
Galantamine—Dermatitis—Etoposide—sarcoma	0.000641	0.00101	CcSEcCtD
Galantamine—Headache—Etoposide—sarcoma	0.000637	0.00101	CcSEcCtD
Galantamine—Flatulence—Doxorubicin—sarcoma	0.000637	0.001	CcSEcCtD
Galantamine—Tension—Doxorubicin—sarcoma	0.000634	0.001	CcSEcCtD
Galantamine—Dysgeusia—Doxorubicin—sarcoma	0.000633	0.000998	CcSEcCtD
Galantamine—Malaise—Epirubicin—sarcoma	0.00063	0.000994	CcSEcCtD
Galantamine—Nervousness—Doxorubicin—sarcoma	0.000628	0.00099	CcSEcCtD
Galantamine—Vertigo—Epirubicin—sarcoma	0.000628	0.00099	CcSEcCtD
Galantamine—Syncope—Epirubicin—sarcoma	0.000627	0.000988	CcSEcCtD
Galantamine—Back pain—Doxorubicin—sarcoma	0.000625	0.000986	CcSEcCtD
Galantamine—Muscle spasms—Doxorubicin—sarcoma	0.000622	0.00098	CcSEcCtD
Galantamine—Palpitations—Epirubicin—sarcoma	0.000617	0.000974	CcSEcCtD
Galantamine—Loss of consciousness—Epirubicin—sarcoma	0.000614	0.000969	CcSEcCtD
Galantamine—Cough—Epirubicin—sarcoma	0.00061	0.000962	CcSEcCtD
Galantamine—Vision blurred—Doxorubicin—sarcoma	0.000609	0.000961	CcSEcCtD
Galantamine—Convulsion—Epirubicin—sarcoma	0.000605	0.000955	CcSEcCtD
Galantamine—Nausea—Etoposide—sarcoma	0.000604	0.000953	CcSEcCtD
Galantamine—Hypertension—Epirubicin—sarcoma	0.000603	0.000951	CcSEcCtD
Galantamine—Ill-defined disorder—Doxorubicin—sarcoma	0.0006	0.000946	CcSEcCtD
Galantamine—Anaemia—Doxorubicin—sarcoma	0.000598	0.000942	CcSEcCtD
Galantamine—Chest pain—Epirubicin—sarcoma	0.000595	0.000938	CcSEcCtD
Galantamine—Arthralgia—Epirubicin—sarcoma	0.000595	0.000938	CcSEcCtD
Galantamine—Myalgia—Epirubicin—sarcoma	0.000595	0.000938	CcSEcCtD
Galantamine—Agitation—Doxorubicin—sarcoma	0.000594	0.000937	CcSEcCtD
Galantamine—Anxiety—Epirubicin—sarcoma	0.000593	0.000935	CcSEcCtD
Galantamine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000591	0.000932	CcSEcCtD
Galantamine—Discomfort—Epirubicin—sarcoma	0.000588	0.000927	CcSEcCtD
Galantamine—Malaise—Doxorubicin—sarcoma	0.000583	0.000919	CcSEcCtD
Galantamine—Dry mouth—Epirubicin—sarcoma	0.000582	0.000918	CcSEcCtD
Galantamine—Vertigo—Doxorubicin—sarcoma	0.000581	0.000916	CcSEcCtD
Galantamine—Syncope—Doxorubicin—sarcoma	0.00058	0.000914	CcSEcCtD
Galantamine—Confusional state—Epirubicin—sarcoma	0.000575	0.000907	CcSEcCtD
Galantamine—Palpitations—Doxorubicin—sarcoma	0.000571	0.000901	CcSEcCtD
Galantamine—Loss of consciousness—Doxorubicin—sarcoma	0.000568	0.000896	CcSEcCtD
Galantamine—Cough—Doxorubicin—sarcoma	0.000564	0.00089	CcSEcCtD
Galantamine—Shock—Epirubicin—sarcoma	0.000561	0.000885	CcSEcCtD
Galantamine—Convulsion—Doxorubicin—sarcoma	0.00056	0.000883	CcSEcCtD
Galantamine—Nervous system disorder—Epirubicin—sarcoma	0.000559	0.000882	CcSEcCtD
Galantamine—Thrombocytopenia—Epirubicin—sarcoma	0.000558	0.000881	CcSEcCtD
Galantamine—Hypertension—Doxorubicin—sarcoma	0.000558	0.00088	CcSEcCtD
Galantamine—Tachycardia—Epirubicin—sarcoma	0.000557	0.000878	CcSEcCtD
Galantamine—Skin disorder—Epirubicin—sarcoma	0.000554	0.000874	CcSEcCtD
Galantamine—Hyperhidrosis—Epirubicin—sarcoma	0.000551	0.000869	CcSEcCtD
Galantamine—Chest pain—Doxorubicin—sarcoma	0.00055	0.000868	CcSEcCtD
Galantamine—Arthralgia—Doxorubicin—sarcoma	0.00055	0.000868	CcSEcCtD
Galantamine—Myalgia—Doxorubicin—sarcoma	0.00055	0.000868	CcSEcCtD
Galantamine—Anxiety—Doxorubicin—sarcoma	0.000548	0.000865	CcSEcCtD
Galantamine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000547	0.000862	CcSEcCtD
Galantamine—Discomfort—Doxorubicin—sarcoma	0.000544	0.000858	CcSEcCtD
Galantamine—Anorexia—Epirubicin—sarcoma	0.000544	0.000857	CcSEcCtD
Galantamine—Dry mouth—Doxorubicin—sarcoma	0.000538	0.000849	CcSEcCtD
Galantamine—Hypotension—Epirubicin—sarcoma	0.000533	0.00084	CcSEcCtD
Galantamine—Confusional state—Doxorubicin—sarcoma	0.000532	0.000839	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Epirubicin—sarcoma	0.00052	0.000819	CcSEcCtD
Galantamine—Shock—Doxorubicin—sarcoma	0.000519	0.000819	CcSEcCtD
Galantamine—Nervous system disorder—Doxorubicin—sarcoma	0.000517	0.000816	CcSEcCtD
Galantamine—Thrombocytopenia—Doxorubicin—sarcoma	0.000517	0.000815	CcSEcCtD
Galantamine—Insomnia—Epirubicin—sarcoma	0.000516	0.000813	CcSEcCtD
Galantamine—Tachycardia—Doxorubicin—sarcoma	0.000515	0.000812	CcSEcCtD
Galantamine—Skin disorder—Doxorubicin—sarcoma	0.000512	0.000808	CcSEcCtD
Galantamine—Paraesthesia—Epirubicin—sarcoma	0.000512	0.000808	CcSEcCtD
Galantamine—Hyperhidrosis—Doxorubicin—sarcoma	0.00051	0.000804	CcSEcCtD
Galantamine—Somnolence—Epirubicin—sarcoma	0.000507	0.0008	CcSEcCtD
Galantamine—Anorexia—Doxorubicin—sarcoma	0.000503	0.000793	CcSEcCtD
Galantamine—Dyspepsia—Epirubicin—sarcoma	0.000502	0.000792	CcSEcCtD
Galantamine—Decreased appetite—Epirubicin—sarcoma	0.000496	0.000782	CcSEcCtD
Galantamine—Hypotension—Doxorubicin—sarcoma	0.000493	0.000778	CcSEcCtD
Galantamine—Gastrointestinal disorder—Epirubicin—sarcoma	0.000492	0.000776	CcSEcCtD
Galantamine—Fatigue—Epirubicin—sarcoma	0.000492	0.000775	CcSEcCtD
Galantamine—Constipation—Epirubicin—sarcoma	0.000488	0.000769	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000481	0.000758	CcSEcCtD
Galantamine—Insomnia—Doxorubicin—sarcoma	0.000477	0.000753	CcSEcCtD
Galantamine—Paraesthesia—Doxorubicin—sarcoma	0.000474	0.000747	CcSEcCtD
Galantamine—Feeling abnormal—Epirubicin—sarcoma	0.00047	0.000741	CcSEcCtD
Galantamine—Somnolence—Doxorubicin—sarcoma	0.000469	0.00074	CcSEcCtD
Galantamine—Gastrointestinal pain—Epirubicin—sarcoma	0.000466	0.000735	CcSEcCtD
Galantamine—Dyspepsia—Doxorubicin—sarcoma	0.000464	0.000733	CcSEcCtD
Galantamine—Decreased appetite—Doxorubicin—sarcoma	0.000459	0.000723	CcSEcCtD
Galantamine—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000456	0.000718	CcSEcCtD
Galantamine—Fatigue—Doxorubicin—sarcoma	0.000455	0.000717	CcSEcCtD
Galantamine—Constipation—Doxorubicin—sarcoma	0.000451	0.000712	CcSEcCtD
Galantamine—Abdominal pain—Epirubicin—sarcoma	0.000451	0.000711	CcSEcCtD
Galantamine—Body temperature increased—Epirubicin—sarcoma	0.000451	0.000711	CcSEcCtD
Galantamine—Feeling abnormal—Doxorubicin—sarcoma	0.000435	0.000686	CcSEcCtD
Galantamine—Gastrointestinal pain—Doxorubicin—sarcoma	0.000431	0.00068	CcSEcCtD
Galantamine—Hypersensitivity—Epirubicin—sarcoma	0.00042	0.000663	CcSEcCtD
Galantamine—Abdominal pain—Doxorubicin—sarcoma	0.000417	0.000658	CcSEcCtD
Galantamine—Body temperature increased—Doxorubicin—sarcoma	0.000417	0.000658	CcSEcCtD
Galantamine—Asthenia—Epirubicin—sarcoma	0.000409	0.000645	CcSEcCtD
Galantamine—Diarrhoea—Epirubicin—sarcoma	0.00039	0.000615	CcSEcCtD
Galantamine—Hypersensitivity—Doxorubicin—sarcoma	0.000389	0.000613	CcSEcCtD
Galantamine—Asthenia—Doxorubicin—sarcoma	0.000379	0.000597	CcSEcCtD
Galantamine—Dizziness—Epirubicin—sarcoma	0.000377	0.000595	CcSEcCtD
Galantamine—Vomiting—Epirubicin—sarcoma	0.000363	0.000572	CcSEcCtD
Galantamine—Diarrhoea—Doxorubicin—sarcoma	0.000361	0.000569	CcSEcCtD
Galantamine—Rash—Epirubicin—sarcoma	0.00036	0.000567	CcSEcCtD
Galantamine—Dermatitis—Epirubicin—sarcoma	0.000359	0.000567	CcSEcCtD
Galantamine—Headache—Epirubicin—sarcoma	0.000357	0.000563	CcSEcCtD
Galantamine—Dizziness—Doxorubicin—sarcoma	0.000349	0.00055	CcSEcCtD
Galantamine—Nausea—Epirubicin—sarcoma	0.000339	0.000534	CcSEcCtD
Galantamine—Vomiting—Doxorubicin—sarcoma	0.000335	0.000529	CcSEcCtD
Galantamine—Rash—Doxorubicin—sarcoma	0.000333	0.000525	CcSEcCtD
Galantamine—Dermatitis—Doxorubicin—sarcoma	0.000332	0.000524	CcSEcCtD
Galantamine—Headache—Doxorubicin—sarcoma	0.000331	0.000521	CcSEcCtD
Galantamine—Nausea—Doxorubicin—sarcoma	0.000313	0.000494	CcSEcCtD
